Key facts
- It has raised $14.0M; the latest was Later Stage VC ($14.0M) in Oct 2025.
- Notable investors include Haiwang Capital, Spinnotec, Shanghai Zhangjiang Torch Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Weiran Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Weiran Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Weiran Technology
Manufacturer of biological and medical instrumentation designed to advance in vitro diagnostics and sample testing workflows. The company offers integrated advanced optical detection systems, customizable instrument configurations, and full technical support, enabling life science researchers and clinical laboratories enhanced testing accuracy and operational efficiency
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2020
- Website
- sh-futech.com/
- Ownership
- Privately Held (backing)
Weiran Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Weiran Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Weiran Technology in its N-PORT filings yet. We sweep new filings monthly.